Bianchini, G., Allignol, A., Logue, A., Saura Manich, C., wildiers, h., & Garcia-Saenz, J. A. (2025). European experience of patients with HER2-positive advanced/metastatic breast cancer accessing trastuzumab deruxtecan through a named patient program: The EUROPA T-DXd study.
Citação norma ChicagoBianchini, Giampaolo, Arthur Allignol, Amanda Logue, Cristina Saura Manich, hans wildiers, y Jose Angel Garcia-Saenz. European Experience of Patients With HER2-positive Advanced/metastatic Breast Cancer Accessing Trastuzumab Deruxtecan Through a Named Patient Program: The EUROPA T-DXd Study. 2025.
Citação norma MLABianchini, Giampaolo, et al. European Experience of Patients With HER2-positive Advanced/metastatic Breast Cancer Accessing Trastuzumab Deruxtecan Through a Named Patient Program: The EUROPA T-DXd Study. 2025.